Alicia D. Henn, Ph.D.
Affiliations: | 2000 | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Molecular Biology, Cell Biology, Animal Physiology BiologyGoogle:
"Alicia Henn"Parents
Sign in to add mentor| M Jane Ehrke | grad student | 2000 | SUNY Buffalo | |
| (Tumor necrosis factor inhibitory protein B -1: A possible role.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Henn A, He Y, Darou S, et al. (2020) Aseptic conditions for antibiotic-free cell processing for cellular therapies Cytotherapy. 22 |
| Darou S, Henn A, Alm K, et al. (2019) Abstract 2157: Eliminating Edge Effect in 96-Well Plates by Controlling Thermal Conditions during Cell Plating Cancer Research. 79: 2157-2157 |
| Henn A, Darou S, Yerden R. (2018) Abstract 2438: Reducing plate edge effect by controlling cell handling conditions for in vitro tumor hypoxia assays Cancer Research. 78: 2438-2438 |
| Henn AD, Darou S, Yerden R. (2018) Scaling of massively parallel patient-specific cell cultures with a transportable conditioned cell culture chamber Biochemical Engineering Journal. 132: 139-144 |
| Henn AD, Darou S, Yerden R. (2016) 714. Use of a Modular Workstation for Reduced Biosafety Risks Also Increased Cellular Yields Molecular Therapy. 24: S281 |
| Henn AD, Darou S, Yerden R. (2015) 471. Cell Incubation Outside of a Barrier Isolator Using an Improved Conditioned Transport Chamber Expands Scale-Out Capacity for Massively Parallel Patient-Specific Batch Production Molecular Therapy. 23: S187 |
| Henn AD, Laski M, Yang H, et al. (2012) Functionally Distinct Subpopulations of CpG-Activated Memory B Cells. Scientific Reports. 2: 345 |
| Henn AD, Rebhahn J, Brown MA, et al. (2009) Modulation of single-cell IgG secretion frequency and rates in human memory B cells by CpG DNA, CD40L, IL-21, and cell division. Journal of Immunology (Baltimore, Md. : 1950). 183: 3177-87 |
| Evans EE, Henn AD, Jonason A, et al. (2006) C35 (C17orf37) is a novel tumor biomarker abundantly expressed in breast cancer. Molecular Cancer Therapeutics. 5: 2919-30 |
| Rossi RM, Henn AD, Conkling R, et al. (2005) The PKCβ Selective Inhibitor, Enzastaurin (LY317615), Inhibits Growth of Human Lymphoma Cells. Blood. 106: 1483-1483 |